Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Arlington, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Eloxx Pharmaceuticals, Inc. has filed 1,350 SEC EDGAR filings since 27 Mar 1997

SEC filing history

Showing 801-825 of 917 matching filings.

Per page
25
Current page
33
4

FORM 4 -

Filing date
19 May 2011
Reporting date
17 May 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
19 May 2011
Reporting date
17 May 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
19 May 2011
Reporting date
17 May 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31326

8-K filing

Filing date
16 May 2011
Reporting date
16 May 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-31326

10-Q filing

Filing date
13 May 2011
Reporting date
31 Mar 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
23 Mar 2011
Reporting date
22 Mar 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
22 Mar 2011
Reporting date
21 Mar 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31326

8-K filing

Filing date
15 Mar 2011
Reporting date
11 Mar 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31326

8-K filing

Filing date
10 Mar 2011
Reporting date
10 Mar 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
24 Feb 2011
Reporting date
23 Feb 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
16 Feb 2011
Reporting date
14 Feb 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
16 Feb 2011
Reporting date
14 Feb 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
16 Feb 2011
Reporting date
14 Feb 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
16 Feb 2011
Reporting date
14 Feb 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
16 Feb 2011
Reporting date
14 Feb 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
16 Feb 2011
Reporting date
14 Feb 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
16 Feb 2011
Reporting date
14 Feb 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
ARS File 001-31326

AUTO-GENERATED PAPER DOCUMENT

Filing date
14 Feb 2011
Reporting date
30 Jun 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-31326

DEF 14A filing

Filing date
11 Feb 2011
Reporting date
11 Mar 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31326

8-K filing

Filing date
10 Feb 2011
Reporting date
10 Feb 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-31326

10-Q filing

Filing date
10 Feb 2011
Reporting date
31 Dec 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31326

8-K filing

Filing date
24 Jan 2011
Reporting date
24 Jan 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31326

8-K filing

Filing date
03 Jan 2011
Reporting date
03 Jan 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31326

8-K filing

Filing date
22 Dec 2010
Reporting date
22 Dec 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-170140

424B5 filing

Filing date
22 Dec 2010
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .